| Prodotto | Codice | Prezzo | ||
|---|---|---|---|---|
| Daratumumab (anti-CD38) | A2027 5mg | 5mg |
€ 838,01 | Contattaci |
| Tiragolumab (anti-TIGIT) | A2028 1mg | 1mg |
€ 280,14 | Contattaci |
| Tiragolumab (anti-TIGIT) | A2028 5mg | 5mg |
€ 852,50 | Contattaci |
| Relatlimab (anti-LAG-3) | A2029 1mg | 1mg |
€ 282,56 | Contattaci |
| Relatlimab (anti-LAG-3) | A2029 5mg | 5mg |
€ 864,57 | Contattaci |
| Siltuximab (anti-IL-6) | A2030 1mg | 1mg |
€ 306,71 | Contattaci |
| Sacituzumab (anti-Trop-2) | A2031 1mg | 1mg |
€ 271,69 | Contattaci |
| Sacituzumab (anti-Trop-2) | A2031 5mg | 5mg |
€ 815,06 | Contattaci |
| Brodalumab (anti-IL17RA) | A2032 1mg | 1mg |
€ 257,20 | Contattaci |
| Brodalumab (anti-IL17RA) | A2032 5mg | 5mg |
€ 769,18 | Contattaci |
| Vibostolimab (anti-TIGIT) | A2033 1mg | 1mg |
€ 425,04 | Contattaci |
| Vibostolimab (anti-TIGIT) | A2033 5mg | 5mg |
€ 1.277,54 | Contattaci |
Selleckchem Chemicals
Selleck Chemicals supplies over 120,000 inhibitors used in the study of cell signaling pathways. We actively tracks the latest science so our customers can rely on us to be the leading supplier of the newest inhibitors. Selleck's Bioactive Screening Libraries consist of over 8,000 small molecules with validated biological and pharmacological activities. The safety and effectiveness of these molecules has been demonstrated through preclinical and clinical research and many of them are FDA-approved compounds.
More information? Contact Us by e-mail info@divbio.it